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Abstract 
Atmospheric pressure plasma jets (APPJ) are investigated as an efficient approach to induce antitumor effects of 
cancerous tissues without inducing any damage (e.g. dessication, burnings). For this, a two-steps methodology has been 
developed where first APPJ are calibrated and characterized on targets mimicking electrical properties of living organisms 
(mice, human body) and second where they are applied on murine models to demonstrate their innocuity and 
therapeutic efficiency. 
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I. Introduction 
 
Biliary tract cancers or cholangiocarcinomas (CCA) are a group of 
biliary tract malignant and aggressive tumor with poor prognosis 
(Fig. 1) [1]. They represent the second most frequent primary liver 
cancers and 3% of all gastrointestinal neoplasia. CCA present an 
overall tendency to increase presenting an incidence between 2-6 
cases per 100,000 people [2]. Importantly, this cancer is usually 
diagnosed in advance stages due to its asymptomatic behaviour 
and the difficulties in monitoring high-risk patients, especially 
primary sclerosing cholangitis (PSC) patients [1] [3]. Nowadays 
surgical resection of the tumor is still the only curative and 
effective therapeutic alternative. However, due to the advanced 
stage of the disease at the diagnosis, only low proportion of 
patients can benefit of this treatment and the recurrence is high 
[2]. When tumor resection is not possible or at recurrence, the 
therapeutic alternatives consist in palliative treatments based on 
chemotherapy regimens with poor results, usually patients 
undergoing palliative chemotherapy present survivals below a 
year [2] [4]. Faced with this alarming finding, the emergence of 
new therapeutic approaches is highly expected. Cold plasmas 
represent a new research avenue where conventional therapies 
appear limited. 
For more than one year, the LPP and the Saint-Antoine Research 
Center (CRSA) carry out joint research on the treatment of 
carcinomas using atmospheric pressure plasma jets (APPJ) as 
therapeutic option. The objective is to determine an experimental 
operating window where plasma therapy can be applied first as a 
safe approach (i.e. without inducing deleterious effects on the 
tissues) and second as an effective approach (i.e. demonstrating 
antitumor effects on in vivo models).  
 
Fig. 1. Anatomical classification of CCAs, percentages represent the 
frequency of each CCA subtype. 
II. Experimental setup 
 
The Fig. 2a shows a configuration of the plasma device engineered 
at LPP and dedicated to medical applications. Supplied with a high 
voltage nanoimpulse generator, it can deliver pulsed atmospheric 
plasma streams (PAPS), i.e. ionization waves with high electric field 
fronts. As photographed in Fig. 2b, the device can be designed 
using shorter dielectric tubes as the one utilized at CRSA to treat 
ectopic CCA tumors on mice models. This “smaller device” has 
been utilized for in vivo campaigns considering two different types 
of electrode configurations: the "plasma gun" configuration, 
where plasma can directly interact with the coaxial HV electrode 
and the "plasma Tesla jet" configuration, where plasma cannot be 
in contact with the HV electrode. 
This document is a pre-print version. You may use it at your own convenience although its content may deviate in places from the final published article. 
 
2 
F. Judée, J. Vaquero, L. Fouassier, T. Dufour, ISPC-24, Naples, Italy, 9-14 June 2019, proceeding Ref. 434, https://www.ispc-
conference.org/ispcproc/ispc24/434.pdf 
 
 
Fig. 2. (a) Overall view of the APPJ utilized for plasma medicine issues, (b) 
picture of the APPJ in plasma gun configuration applied on a mouse 
model to treat carcinoma. 
III. Calibration and characterization 
of plasma sources interacting with 
targets (at physics laboratory) 
 
Before carrying out in vivo campaigns at CRSA, physico-chemical 
properties of the two APPJ configurations have been studied while 
interacting with different types of targets: liquid interfaces, 
dielectric and metal plates as well as targets mimicking the 
electrical properties of living organisms. 
The relative efficiency of the APPJ in producing reactive species has 
been studied while interacting with aqueous interfaces. In the case 
of the plasma gun configuration, Fig 3a and 3b show how [NO2-] 
and [H2O2] are increased as a function of the duty cycle and 
repetition frequency parameters. Highest amounts of reactive 
species at the lowest plasma energy (EPL) are obtained for 
repetition frequency close to 30 kHz and duty cycle lower than 
10%. The values of these electrical parameters have been utilized 
for the in vivo campaigns. 
 
Besides, gas flowing dynamics have been studied using space 
resolved mass spectrometry as shown in Fig. 4 for plasma 
interacting with dielectric and metal targets as well as an 
equivalent electrical human body target (EEHB). This latter model 
includes a resistor of 1500  and a capacitor of 100 pF [5]. For the 
same operating conditions, the helium and air flow space 
distributions can reveal quite different and – in some cases – drive 
to electrical hazards. As an example, the space distributions of 
helium and air appear monodirectional with metal target at 
floating potential while it broadens on dielectric targets, especially 
in the case of the plasma Tesla jet. Besides, while no electrical 
hazards are detectable using dielectric and metal plates, the 
utilization of the EEHB target permits to evidence in some cases 
glow-to-arc transitions, likely to cause severe damages of tissues 
and endanger patient safety. 
 
 
Fig. 3. Influence of plasma electrical parameters (repetition frequency 
and duty cycle) on the energetic molar production rates of (a) nitrites and 
(b) H2O2, considering the plasma gun configuration. 
 
Fig. 4. Mass spectrometry 2D profiles of plasma plumes generated either 
with plasma gun or plasma Tesla jet interacting with various targets 
either at floating potential (dielectric and metal target) or at grounded 
potential (Equivalent Electrical Human Body target) 
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IV. Innocuity and therapeutic 
efficiency (in vivo campaigns) 
Plasma innocuity has been studied first by treating healthy tissues 
of mice models and second by assessing skin anatomy and 
physiology through H&E analysis as well as camera imaging for 
several days. While mild and severe damages could be obtained in 
specific conditions using our plasma gun configuration (Fig. 5), no 
deleterious effects were observed on the tissues exposed to the 
plasma Tesla jet device. H&E analyses confirmed these 
observations after examination of hypodermis, dermis and 
epidermis layers. 
 
Fig. 5. Types of healthy skin damages obtained after exposure to APPJ in 
plasma gun configuration. 
The search for anti-tumor effects was the subject of a first study 
with the plasma gun configuration. For this, two groups of 8 mice 
with subcutaneous CCA were carried out: a control group (no 
treatment) and a plasma group where tumors were exposed to 
plasma for 2 min/session. The evolution of tumor volumes as a 
function of time is shown in Fig. 6. After two plasma exposures at 
days 13 and 20, no antitumor effect was found since no difference 
in tumor volume could be evidenced between control and plasma 
groups. Then, as an alternative, the second APPJ device was 
utilized using same experimental conditions at days 34 and 41. As 
a result, Fig. 6 clearly shows that the tumor volume rise is 
significantly reduced in the case of the plasma group [6]. 
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Fig. 6. Tumor volume follow-up as a function of time considering two mice 
groups: control (N=8) and plasma (N=8). Plasma treatments are achieved 
using the plasma gun at days 13 and 20 while plasma Tesla jet at days 34 
and 42 [6]. 
We have also compared the efficacy of plasma therapy with 
conventional treatment based on chemotherapy. In Fig. 7, a time 
follow-up of tumor volumes is represented for three groups of 
mice with subcutaneous tumors: a control group, a group of mice 
exposed to plasma and a group of mice treated with gemcitabine 
(drug administered to patients in palliative care). Red arrows 
indicate the frequency of plasma or gemcitabine treatments (i.e. 
approximately every 3 days). It appears that tumor volumes 
treated with gemcitabine are greatly reduced and stabilize at day 
35, while the mean tumor volume of the plasma group is 
significantly reduced compared to the control group. Tumors 
extracted from their hosts are photographed on the right of Fig. 3: 
while the tumors in the control group are the largest and present 
a vascular system, tumors in the plasma group appear smaller and 
undamaged. 
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Fig. 7. Tumor volume follow-up as a function of time considering three 
mice groups: control (N=8) plasma (N=8) and gemcitabine (N=8). 
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